Page last updated: 2024-08-25

artemisinin and Delayed Effects, Prenatal Exposure

artemisinin has been researched along with Delayed Effects, Prenatal Exposure in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Augusto, O; Calip, GS; d'Alessandro, U; Dellicour, S; Desai, M; Kazienga, A; Macete, E; Menendez, C; Nakanabo-Diallo, S; Ouma, P; Ruperez, M; Sevene, E; Sorgho, H; Stergachis, A; Ter Kuile, F; Tinto, H; Valá, A; Valea, I	1
Clark, RL; Cox, EM; Gristwood, WE; Lerman, SA; White, TE	1

Other Studies

2 other study(ies) available for artemisinin and Delayed Effects, Prenatal Exposure

Article	Year
Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique. Reproductive health, 2015, Dec-04, Volume: 12 Topics: Antimalarials; Artemisinins; Clinical Protocols; Cohort Studies; Drug Administration Schedule; Female; Gestational Age; Humans; Infant, Newborn; Malaria; Maternal-Fetal Exchange; Patient Selection; Pharmacovigilance; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Prospective Studies; Research Design; Sample Size	2015
Developmental toxicity of artesunate in the rat: comparison to other artemisinins, comparison of embryotoxicity and kinetics by oral and intravenous routes, and relationship to maternal reticulocyte count. Birth defects research. Part B, Developmental and reproductive toxicology, 2008, Volume: 83, Issue:4 Topics: Administration, Oral; Animals; Artemether; Artemisinins; Artesunate; Cesarean Section; Drug Administration Routes; Embryo Loss; Embryo, Mammalian; Female; Fetus; Injections, Intravenous; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Reticulocyte Count; Reticulocytes	2008

Article

Year

Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique.

Reproductive health, 2015, Dec-04, Volume: 12

Topics: Antimalarials; Artemisinins; Clinical Protocols; Cohort Studies; Drug Administration Schedule; Female; Gestational Age; Humans; Infant, Newborn; Malaria; Maternal-Fetal Exchange; Patient Selection; Pharmacovigilance; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Prospective Studies; Research Design; Sample Size

2015

Developmental toxicity of artesunate in the rat: comparison to other artemisinins, comparison of embryotoxicity and kinetics by oral and intravenous routes, and relationship to maternal reticulocyte count.

Birth defects research. Part B, Developmental and reproductive toxicology, 2008, Volume: 83, Issue:4

Topics: Administration, Oral; Animals; Artemether; Artemisinins; Artesunate; Cesarean Section; Drug Administration Routes; Embryo Loss; Embryo, Mammalian; Female; Fetus; Injections, Intravenous; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Reticulocyte Count; Reticulocytes

2008